Details van artikel 274 van 426 gevonden artikelen
3 Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations
Titel:
3 Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations
Auteur:
Weberpals, J. Oza, A. Lorusso, D. Scambia, G. Aghajanian, C. Oaknin, A. Dean, A. Colombo, N. Clamp, A.R. Leary, A. Holloway, R.W. Amenedo Gancedo, M. Fong, P.C. Goh, J.C. O’Malley, D.M. Armstrong, D.K. Banerjee, S. García-Donas, J. Swisher, E.M. Cameron, T. Maloney, L. Goble, S. Coleman, R.L. Ledermann, J.A.
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 30 () nr. S3 pagina's A2-A3
Jaar:
2020
Inhoud:
Uitgever:
Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 274 van 426 gevonden artikelen